Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Whatsapp Health Education Message

Research Leaders

7 sponsors active, led by Turku University Hospital

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 4 (1)

Trial Status

Completed2
Unknown1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT05627622Not ApplicableActive Not RecruitingPrimary

Effectiveness of WhatsApp Education and Support Messages for Urolithiasis Prevention

NCT05317273Completed

Urosepsis in Patients With Urinary Tract Calculi Receiving Surgical Intervention

NCT04963062Phase 4CompletedPrimary

Moses vs. Thulium Laser Study

NCT03257306Not ApplicableUnknownPrimary

Magnetic Ureteral Stent Symptoms - a Comparison to Standard Ureteral Stent as Perceived By the Patient (MAGUSS)

Showing all 4 trials

Research Network

Common Treatments

  • Whatsapp Health Education Message1
  • Holmium Laser With Moses Lasers1
  • Ureteral Doublej Stent Removal Using Magnet1
  • Holmium Laser With Thulium Lasers1
  • Ureteral Doublej Stent Removal Using Cystoscopy1

Active Sponsors

  • Turku University Hospital1
  • Rabin Medical Center1
  • Mahidol University1
  • Jyväskylä Central Hospital1
  • Kuopio University Hospital1

Top Investigators

Related Conditions

  • Kidney Stone1
  • Urosepsis1

Activity Timeline